Category: Baxter International
Baxter International says it will keep its headquarters in Illinois, despite recent reports of a possible move to Boston, but stays coy on its actual plans in The Hub.
The Boston Business Journal reports that Baxter International is moving its corporate headquarters from Deerfield, Ill. to Cambridge, Mass.
MASSDEVICE ON CALL — Healthcare industry giant Baxter (NYSE:BAX) is moving its corporate headquarters to Massachusetts in a sneaky plot dubbed "Project Tiger" by Bay State economic and business officials, according to a Boston Business Journal report.
Baxter will more than double its Opelika, Ala., workforce after putting $300 million into expanding its dialyzer manufacturing facility.
Medtech titan Baxter (NYSE:BAX) is looking to hire 200 new workers to man its growing facility in Alabama as global demand grows for hemodialysis devices.
Baxter International recalls 2 lots of its peritoneal dialysis solution after finding potential contamination during the manufacturing process.
Baxter (NYSE:BAX) is pulling back 2 lots of its peritoneal dialysis solution over concerns that the product may have been contaminated during the manufacturing process.
Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M
Illinois healthcare giant Baxter sells its commercial vaccines division ahead of a larger transformation that will split its medical products and pharmaceuticals businesses into separate entities.
Baxter (NYSE:BAX) agreed to offload its commercial vaccines business to pharmaceutical rival Pfizer (NYSE:PFE) for $635 million in cash.
Baxter reports 2nd-quarter sales growth of more than 16% and beats earnings expectations, but narrows its full-year earnings guidance.